Top
image credit: Freepik

FDA Approves Botox Competitor That Lasts Longer

September 9, 2022

Via: Drugs.com
Category:

People wanting to keep wrinkles at bay will soon have a new option now that the U.S. Food and Drug Administration has approved the first competitor for Botox in decades.

Daxxify, made by Revance Therapeutics Inc. in Nashville, Tenn., is injected into the face along worry lines. It lasts longer than Botox, with about 80% of users seeing no or mild facial lines at four months after injection. For half of users, the treatment lasted six months, the company said in a statement.

Read More on Drugs.com